Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5346538 | 1.00 | ADRB2 (0.39) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL3871723 | 0.95 | ADRB2 (0.36) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| Methylamine SCHEMBL201624 | 0.95 | ADRB2 (0.42) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL1608608 | 0.92 | THRB (0.35) | TSHRALDH1A1CA1CA2THRB | |
| SCHEMBL3321056 | 0.92 | THRB (0.35) | TSHRALDH1A1CA1CA2THRB | |
| SCHEMBL310148 | 0.91 | ADRB2 (0.45) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL17391451 | 0.90 | THRB (0.40) | TSHRALDH1A1CA1CA2THRB | |
| SCHEMBL4429193 | 0.90 | THRB (0.40) | TSHRALDH1A1CA1CA2THRB | |
| SCHEMBL28719230 | 0.90 | ADRB2 (0.36) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL17391430 | 0.90 | THRB (0.40) | TSHRALDH1A1CA1CA2THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2272878-B1 | Coupled polymers and manufacturing method thereof | TSRC CORP (TW) | 2013-12-18 | — | — | EP | claimed |
| US-8481649-B2 | Coupled polymers and manufacturing method thereof | TSRC CORPORATION (TW) | 2013-07-09 | — | — | US | claimed |
| US-20110009588-A1 | COUPLED POLYMERS AND MANUFACTURING METHOD THEREOF | TSRC CORPORATION (TW) | 2011-01-13 | — | — | US | claimed |
| EP-2272878-A1 | Coupled polymers and manufacturing method thereof | TSRC Corporation (TW) | 2011-01-12 | — | — | EP | claimed |
| US-9657039-B2 | Production method for alkoxysilanes | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2017-05-23 | — | — | US | disclosed |
| US-20160002271-A1 | PRODUCTION METHOD FOR ALKOXYSILANES | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2016-01-07 | — | — | US | disclosed |
| EP-2872461-A2 | POWDER MIXTURE AND PROCESS TO MAKE DRY MORTAR | Akzo Nobel Chemicals International B.V. (NL) | 2015-05-20 | — | — | EP | disclosed |
| WO-2014009299-A2 | POWDER MIXTURE AND PROCESS TO MAKE DRY MORTAR | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) | 2014-01-16 | — | — | WO | disclosed |
| EP-2272878-B1 | Coupled polymers and manufacturing method thereof | TSRC CORP (TW) | 2013-12-18 | — | — | EP | disclosed |
| US-8481649-B2 | Coupled polymers and manufacturing method thereof | TSRC CORPORATION (TW) | 2013-07-09 | — | — | US | disclosed |
| CN-102212196-B | Coupled copolymer and method for producing the same | TSRC CORP | 2013-03-06 | — | — | CN | disclosed |
| US-20110009588-A1 | COUPLED POLYMERS AND MANUFACTURING METHOD THEREOF | TSRC CORPORATION (TW) | 2011-01-13 | — | — | US | disclosed |
| EP-2272878-A1 | Coupled polymers and manufacturing method thereof | TSRC Corporation (TW) | 2011-01-12 | — | — | EP | disclosed |
| EP-0691362-B1 | Method of producing organopolysiloxanes containing hydrolyzable functional groups, and curable resin composition using said organopolysiloxanes | SHINETSU CHEMICAL CO (JP) | 2000-10-25 | — | — | EP | disclosed |
| US-5633311-A | ROOM TEMPERATURE CURABLE RESIN | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1997-05-27 | — | — | US | disclosed |
| EP-0691362-A2 | Method of producing organopolysiloxanes containing hydrolyzable functional groups, and curable resin composition using said organopolysiloxanes | Shin-Etsu Chemical Co., Ltd. (JP) | 1996-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160002271-A1 | PRODUCTION METHOD FOR ALKOXYSILANES | MSMO1, MGAM, MACO1 | ADRB2 3721/4885ADRB1 3712/4885ADRB3 3956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.